Disease-free survival (DFS) study (Figure 3(b)) revealed an association between higher HNRNPA2B1 expression levels and poor DFS rates in ACC (P = 4.7e − 05), KICH (P = 0.043), LGG (P = 0.0012), LIHC (P = 0.043), and LUAD (P = 0.012). Here, HNRNPA2B1 is linked to adrenal cortex carcinoma.